Cited by 227Dermatology and Skin DiseasesAcne and Rosacea Treatments and EffectsContact Dermatitis and Allergies

Staphylococcus epidermidis and Cutibacterium acnes: Two Major Sentinels of Skin Microbiota and the Influence of Cosmetics

Open access
Fournière, Mathilde, Latire, Thomas, Souak, Djouhar, Feuilloley, Marc G. J., Bedoux, Gilles·2020·Microorganisms

Abstract

Dermatological and cosmetics fields have recently started to focus on the human skin microbiome and microbiota, since the skin microbiota is involved in the health and dysbiosis of the skin ecosystem. Amongst the skin microorganisms, Staphylococcus epidermidis and Cutibacterium acnes, both commensal bacteria, appear as skin microbiota sentinels. These sentinels have a key role in the skin ecosystem since they protect and prevent microbiota disequilibrium by fighting pathogens and participate in skin homeostasis through the production of beneficial bacterial metabolites. These bacteria adapt to changing skin microenvironments and can shift to being opportunistic pathogens, forming biofilms, and thus are involved in common skin dysbiosis, such as acne or atopic dermatitis. The current evaluation methods for cosmetic active ingredient development are discussed targeting these two sentinels with their assets and limits. After identification of these objectives, research of the active cosmetic ingredients and products that maintain and promote these commensal metabolisms, or reduce their pathogenic forms, are now the new challenges of the skincare industry in correlation with the constant development of adapted evaluation methods.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/microorganisms8111752

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the skin, four defense levels can be identified: physical, chemical, and immune barriers inherent to the tissue, plus the skin microbiota, which provides an additional barrier.

    “In the skin, four defense levels can be identified: besides the physical, chemical, and immune barriers that are inherent to the tissue, the skin microbiota (i.e., the numerous microorganisms living on the skin surface) provides an additional barrier.”

    From Recreating Human Skin In Vitro: Should the Microbiota Be Taken into Account? (2024) · cites this paper as [4]

    The Introduction describes the stratum corneum as a physical barrier and says skin microorganisms help maintain the skin barrier and immune system while limiting pathogen growth. Section 2.1 also describes antimicrobial substances produced by commensal bacteria. The paper does not identify four distinct defense levels or describe a separate chemical barrier inherent to the tissue; page numbers are unavailable in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • The skin consists of four morphologically and functionally related barriers-physical, chemical, immune, and microbiotic-that form an interactive network whose disruption may lead to infection, inflammation, allergy, or cancer.

    “As already recalled, the skin has been described as consisting of four morphologically and functionally related barriers: the physical, chemical, immune, and microbiotic barriers that form an interactive network whose disruption may lead to infection, inflammation, allergy, or even cancer [4,5].”

    From Recreating Human Skin In Vitro: Should the Microbiota Be Taken into Account? (2024) · cites this paper as [4]

    The Introduction describes a physical barrier and says skin microorganisms help maintain the skin barrier and immune system. Section 2.2 links barrier disturbance and microbiota imbalance with inflammatory skin disease, but says the causal relationship remains unclear. The paper does not describe the claimed four-barrier framework or link its disruption to allergy or cancer; page numbers are not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The skin microbiota, or dermobiota, comprises bacteria, fungi, viruses, archaea, and mites on the skin surface and forms a complex ecosystem that keeps pathogenic bacteria under control and releases activating/modulating substances for epidermal and immune cells, favoring maintenance of whole barrier functions.

    “the skin microbiota, or dermobiota (i.e., the bacteria, fungi, viruses, archaea, and mites present on the skin surface) forms a complex ecosystem that keeps pathogenic bacteria under control and releases activating/modulating substances for the epidermal and immune cells, thus favoring the maintenance of the whole barrier functions [4,5].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 195

  1. [1]Dréno B. Araviiskaia E. Berardesca E. Gontijo G. Sanchez Viera M. Xiang L.F. Martin R. Bieber T. Microbiome in healthy skin, update for dermatologists J. Eur. Acad. Dermatol. Venereol. 2016 30 2038 2047 10.1111/jdv.13965 27735094 PMC6084363 · DOI · Paper page
  2. [2]Oh J. Byrd A.L. Deming C. Conlan S. NISC Comparative Sequencing Program Kong H.H. Segre J.A. Biogeography and individuality shape function in the human skin metagenome Nature 2014 514 59 64 10.1038/nature13786 25279917 PMC4185404 · DOI · Paper page
  3. [3]Huttenhower C. Gevers D. Knight R. Abubucker S. Badger J.H. Chinwalla A.T. Creasy H.H. Earl A.M. Fitzgerald M.G. Fulton R.S. Structure, function and diversity of the healthy human microbiome Nature 2012 486 207 214 22699609 PMC3564958
  4. [4]Grice E.A. Segre J.A. The skin microbiome Nat. Rev. Microbiol. 2011 9 244 253 10.1038/nrmicro2537 21407241 PMC3535073 · DOI · Paper page
  5. [5]Dethlefsen L. McFall-Ngai M. Relman D.A. An ecological and evolutionary perspective on humang-microbe mutualism and disease Nature 2007 449 811 818 10.1038/nature06245 17943117 PMC9464033 · DOI · Paper page
  6. [6]Wilson M. Houpt E.R. An introduction to the human–microbe symbiosis Microbial Inhabitants of Humans: Their Ecology and Role in Health and Disease Cambridge University Press Cambridge, UK 2005 1 50 9780511735080
  7. [8]Gao Z. Perez-Perez G.I. Chen Y. Blaser M.J. Quantitation of major human cutaneous bacterial and fungal populations J. Clin. Microbiol. 2010 48 3575 3581 10.1128/JCM.00597-10 20702672 PMC2953113 · DOI
  8. [9]Foulongne V. Sauvage V. Hebert C. Dereure O. Cheval J. Gouilh M.A. Pariente K. Segondy M. Burguière A. Manuguerra J.-C. Human Skin Microbiota: High Diversity of DNA Viruses Identified on the Human Skin by High Throughput Sequencing PLoS ONE 2012 7 e38499 10.1371/journal.pone.0038499 22723863 PMC3378559 · DOI
  9. [10]Probst A.J. Auerbach A.K. Moissl-Eichinger C. Archaea on Human Skin PLoS ONE 2013 8 e65388 10.1371/journal.pone.0065388 23776475 PMC3680501 · DOI
  10. [11]Lacey N. Kavanagh K. Tseng S.C.G. Under the lash: Demodex mites in human diseases Biochemist 2009 31 20 24 10.1042/BIO03104020 PMC2906820 20664811 · DOI
  11. [12]Robinson P.J. Skin Encyclopedia of Toxicology 3rd ed. Elsevier Amsterdam, The Netherlands 2014 283 309 9780123864543
  12. [13]Wilkes G.L. Brown I.A. Wildnauer R.H. The biomechanical properties of skin CRC Crit. Rev. Bioeng. 1973 1 453 495 4581809
  13. [14]Proksch E. Brandner J.M. Jensen J.-M. The skin: An indispensable barrier Exp. Dermatol. 2008 17 1063 1072 10.1111/j.1600-0625.2008.00786.x 19043850 · DOI · Paper page
  14. [15]Wilson M. The Indigenous Microbiota of the Skin The Human Microbiota in Health and Disease: An Ecological and Community-Based Approach Garland Science Taylor & Francis Cambridge, UK 2018 86 95 978-0815345855
  15. [16]Karkman A. Lehtimäki J. Ruokolainen L. The ecology of human microbiota: Dynamics and diversity in health and disease Ann. N. Y. Acad. Sci. 2017 1399 78 92 10.1111/nyas.13326 28319653 · DOI
  16. [17]Kong H.H. Segre J.A. Skin Microbiome: Looking Back to Move Forward J. Investig. Dermatol. 2012 132 933 939 10.1038/jid.2011.417 22189793 PMC3279608 · DOI
  17. [19]Grice E.A. Kong H.H. Conlan S. Deming C.B. Davis J. Young A.C. Bouffard G.G. Blakesley R.W. Murray P.R. Green E.D. Topographical and Temporal Diversity of the Human Skin Microbiome Science (80-.) 2009 324 1190 1192 10.1126/science.1171700 PMC2805064 19478181 · DOI · Paper page
  18. [20]Bouslimani A. Porto C. Rath C.M. Wang M. Guo Y. Gonzalez A. Berg-Lyon D. Ackermann G. Moeller Christensen G.J. Nakatsuji T. Molecular cartography of the human skin surface in 3D Proc. Natl. Acad. Sci. USA 2015 112 E2120 E2129 10.1073/pnas.1424409112 25825778 PMC4418856 · DOI
  19. [21]Dominguez-Bello M.G. Costello E.K. Contreras M. Magris M. Hidalgo G. Fierer N. Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns Proc. Natl. Acad. Sci. USA 2010 107 11971 11975 10.1073/pnas.1002601107 20566857 PMC2900693 · DOI · Paper page
  20. [23]Ladizinski B. McLean R. Lee K.C. Elpern D.J. Eron L. The human skin microbiome Int. J. Dermatol. 2014 53 1177 1179 10.1111/ijd.12609 25070027 · DOI
  21. [24]Mueller N.T. Bakacs E. Combellick J. Grigoryan Z. Dominguez-Bello M.G. The infant microbiome development: Mom matters Trends Mol. Med. 2015 21 109 117 10.1016/j.molmed.2014.12.002 25578246 PMC4464665 · DOI · Paper page
  22. [26]Sfriso R. Egert M. Gempeler M. Voegeli R. Campiche R. Revealing the secret life of skin-with the microbiome you never walk alone Int. J. Cosmet. Sci. 2019 42 116 126 10.1111/ics.12594 31743445 PMC7155096 · DOI
  23. [27]Grice E.A. The intersection of microbiome and host at the skin interface: Genomic-and metagenomic-based insights Genome Res. 2015 25 1514 1520 10.1101/gr.191320.115 26430162 PMC4579337 · DOI
  24. [28]Douglas H.C. Gunter S.E. The Taxonomic Position of Corynebacterium acnes J. Bacteriol. 1946 52 15 23 10.1128/JB.52.1.15-23.1946 20994865 · DOI
  25. [29]Scholz C.F.P. Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int. J. Syst. Evol. Microbiol. 2016 66 4422 4432 10.1099/ijsem.0.001367 27488827 · DOI
  26. [30]Dagnelie M.-A. Corvec S. Saint-Jean M. Bourdès V. Nguyen J.M. Khammari A. Dréno B. Decrease in diversity of Propionibacterium acnes phylotypes in patients with severe acne on the back Acta Derm. Venereol. 2018 98 262 267 10.2340/00015555-2847 29136261 · DOI
  27. [31]McDowell A. Over a Decade of recA and tly Gene Sequence Typing of the Skin Bacterium Propionibacterium acnes: What Have We Learnt? Microorganisms 2017 6 1 10.3390/microorganisms6010001 PMC5874615 29267255 · DOI
  28. [32]Fitz-Gibbon S. Tomida S. Chiu B.-H. Nguyen L. Du C. Liu M. Elashoff D. Erfe M.C. Loncaric A. Kim J. Propionibacterium acnes strain populations in the human skin microbiome associated with acne J. Investig. Dermatol. 2013 133 2152 2160 10.1038/jid.2013.21 23337890 PMC3745799 · DOI
  29. [33]Corvec S. Dagnelie M.-A. Khammari A. Dréno B. Taxonomy and phylogeny of Cutibacterium (formerly Propionibacterium) acnes in inflammatory skin diseases Ann. Dermatol. Venereol. 2019 146 26 30 10.1016/j.annder.2018.11.002 30558958 · DOI
  30. [34]Jahns A.C. Alexeyev O.A. Three dimensional distribution of Propionibacterium acnes biofilms in human skin Exp. Dermatol. 2014 23 687 689 10.1111/exd.12482 24980271 · DOI
  31. [37]Percoco G. Methods and results in 3D skin biopsies Proceedings of the The Microbiome of the Skin-New Avenues of Research, in cosmetics Amsterdam, The Netherlands 17 April 2018
  32. [38]Cogen A.L. Nizet V. Gallo R.L. Skin microbiota: A source of disease or defence? Br. J. Dermatol. 2008 158 442 455 10.1111/j.1365-2133.2008.08437.x 18275522 PMC2746716 · DOI
  33. [39]Brüggemann H. Skin: Acne and Propionibacterium acnes Genomics Handbook of Hydrocarbon and Lipid Microbiology Springer Berlin/Heidelberg, Germany 2010 3215 3225 978-3-540-77587-4
  34. [40]Arrecubieta C. Lee M.-H. Macey A. Foster T.J. Lowy F.D. SdrF, a Staphylococcus epidermidis Surface Protein, Binds Type I Collagen J. Biol. Chem. 2007 282 18767 18776 10.1074/jbc.M610940200 17472965 · DOI
  35. [41]Sanford J.A. Gallo R.L. Functions of the skin microbiota in health and disease Semin. Immunol. 2013 25 370 377 10.1016/j.smim.2013.09.005 24268438 PMC4219649 · DOI
  36. [43]Wiesner J. Vilcinskas A. Antimicrobial peptides: The ancient arm of the human immune system Virulence 2010 1 440 464 10.4161/viru.1.5.12983 21178486 · DOI
  37. [44]Claudel J.P. Auffret N. Leccia M.T. Poli F. Corvec S. Dréno B. Staphylococcus epidermidis: A Potential New Player in the Physiopathology of Acne? Dermatology 2019 235 287 294 10.1159/000499858 31112983 · DOI
  38. [45]O’Neill A.M. Gallo R.L. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris Microbiome 2018 6 177 10.1186/s40168-018-0558-5 30285861 PMC6169095 · DOI · Paper page
  39. [46]Christensen G.J.M. Brüggemann H. Bacterial skin commensals and their role as host guardians Benef. Microbes 2014 5 201 215 10.3920/BM2012.0062 24322878 · DOI
  40. [47]Kies S. Vuong C. Hille M. Peschel A. Meyer C. Götz F. Otto M. Control of antimicrobial peptide synthesis by the agr quorum sensing system in Staphylococcus epidermidis: Activity of the lantibiotic epidermin is regulated at the level of precursor peptide processing Peptides 2003 24 329 338 10.1016/S0196-9781(03)00046-9 12732329 · DOI
  41. [48]Iwase T. Uehara Y. Shinji H. Tajima A. Seo H. Takada K. Agata T. Mizunoe Y. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization Nature 2010 465 346 349 10.1038/nature09074 20485435 · DOI · Paper page
  42. [49]Vandecandelaere I. Depuydt P. Nelis H.J. Coenye T. Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms Pathog. Dis. 2014 70 321 331 10.1111/2049-632X.12133 24436195 · DOI
  43. [50]Cogen A.L. Yamasaki K. Muto J. Sanchez K.M. Crotty Alexander L. Tanios J. Lai Y. Kim J.E. Nizet V. Gallo R.L. Staphylococcus epidermidis Antimicrobial δ-Toxin (Phenol-Soluble Modulin-γ) Cooperates with Host Antimicrobial Peptides to Kill Group A Streptococcus PLoS ONE 2010 5 e8557 10.1371/journal.pone.0008557 20052280 PMC2796718 · DOI · Paper page
  44. [52]Shu M. Wang Y. Yu J. Kuo S. Coda A. Jiang Y. Gallo R.L. Huang C.M. Fermentation of Propionibacterium acnes, a Commensal Bacterium in the Human Skin Microbiome, as Skin Probiotics against Methicillin-Resistant Staphylococcus aureus PLoS ONE 2013 8 e55380 10.1371/journal.pone.0055380 23405142 PMC3566139 · DOI
  45. [53]Wang Y. Kuo S. Shu M. Yu J. Huang S. Dai A. Two A. Gallo R.L. Huang C.-M. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: Implications of probiotics in acne vulgaris Appl. Microbiol. Biotechnol. 2014 98 411 424 10.1007/s00253-013-5394-8 24265031 PMC3888247 · DOI
  46. [54]Wanke I. Steffen H. Christ C. Krismer B. Götz F. Peschel A. Schaller M. Schittek B. Skin Commensals Amplify the Innate Immune Response to Pathogens by Activation of Distinct Signaling Pathways J. Investig. Dermatol. 2011 131 382 390 10.1038/jid.2010.328 21048787 · DOI
  47. [55]Percoco G. Merle C. Jaouen T. Ramdani Y. Bénard M. Hillion M. Mijouin L. Lati E. Feuilloley M.G.J. Lefeuvre L. Antimicrobial peptides and pro-inflammatory cytokines are differentially regulated across epidermal layers following bacterial stimuli Exp. Dermatol. 2013 22 800 806 10.1111/exd.12259 24118337 · DOI
  48. [56]Yuki T. Yoshida H. Akazawa Y. Komiya A. Sugiyama Y. Inoue S. Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes J. Immunol. 2011 187 3230 3237 10.4049/jimmunol.1100058 21841130 · DOI
  49. [58]Wang Z. MacLeod D.T. Di Nardo A. Commensal Bacteria Lipoteichoic Acid Increases Skin Mast Cell Antimicrobial Activity against Vaccinia Viruses J. Immunol. 2012 189 1551 1558 10.4049/jimmunol.1200471 22772452 PMC3411879 · DOI
  50. [59]Xia X. Li Z. Liu K. Wu Y. Jiang D. Lai Y. Staphylococcal LTA-induced miR-143 inhibits Propionibacterium acnes-Mediated inflammatory response in skin J. Investig. Dermatol. 2016 136 621 630 10.1016/j.jid.2015.12.024 26739093 · DOI
  51. [60]Wang Y. Kao M.S. Yu J. Huang S. Marito S. Gallo R.L. Huang C.M. A precision microbiome approach using sucrose for selective augmentation of Staphylococcus epidermidis fermentation against Propionibacterium acnes Int. J. Mol. Sci. 2016 17 1870 10.3390/ijms17111870 PMC5133870 27834859 · DOI
  52. [61]Skabytska Y. Biedermann T. Staphylococcus epidermidis Sets Things Right Again J. Investig. Dermatol. 2016 136 559 560 10.1016/j.jid.2015.11.016 26902125 · DOI
  53. [62]Dréno B. Martin R. Moyal D. Henley J.B. Khammari A. Seité S. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne Exp. Dermatol. 2017 26 798 803 10.1111/exd.13296 28094874 · DOI
  54. [63]Brandwein M. Steinberg D. Meshner S. Microbial biofilms and the human skin microbiome NPJ Biofilms Microbiomes 2016 2 3 10.1038/s41522-016-0004-z 28649397 PMC5460139 · DOI
  55. [64]Gonzalez T. Biagini Myers J.M. Herr A.B. Khurana Hershey G.K. Staphylococcal Biofilms in Atopic Dermatitis Curr. Allergy Asthma Rep. 2017 17 81 10.1007/s11882-017-0750-x 29063212 PMC6016544 · DOI
  56. [65]Allen H.B. Mueller J.L. A novel finding in atopic dermatitis: Film-producing Staphylococcus epidermidis as an etiology Int. J. Dermatol. 2011 50 992 993 10.1111/j.1365-4632.2010.04648.x 21781075 · DOI
  57. [66]Clausen M.L. Agner T. Lilje B. Edslev S.M. Johannesen T.B. Andersen P.S. Association of disease severity with skin microbiome and filaggrin gene mutations in adult atopic dermatitis JAMA Dermatol. 2018 154 293 300 10.1001/jamadermatol.2017.5440 29344612 PMC5885821 · DOI
  58. [67]David Boothe W. Tarbox J.A. Tarbox M.B. Atopic Dermatitis: Pathophysiology Adv. Exp. Med. Biol. 2017 1027 21 37 29063428
  59. [68]Byrd A.L. Deming C. Cassidy S.K.B. Harrison O.J. Ng W.I. Conlan S. Belkaid Y. Segre J.A. Kong H.H. Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis Sci. Transl. Med. 2017 9 eaal4651 10.1126/scitranslmed.aal4651 28679656 PMC5706545 · DOI
  60. [69]Costerton W. Veeh R. Shirtliff M. Pasmore M. Post C. Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections J. Clin. Investig. 2003 112 1466 1477 10.1172/JCI200320365 14617746 PMC259139 · DOI
  61. [70]Allen H.B. Vaze N.D. Choi C. Hailu T. Tulbert B.H. Cusack C.A. Joshi S.G. The presence and impact of biofilm-producing staphylococci in atopic dermatitis JAMA Dermatol. 2014 150 260 265 10.1001/jamadermatol.2013.8627 24452476 · DOI
  62. [71]Otto M. Staphylococcal biofilms Curr. Top. Microbiol. Immunol. 2008 322 207 228 18453278 PMC2777538
  63. [72]Cheung G.Y.C. Joo H.S. Chatterjee S.S. Otto M. Phenol-soluble modulins-critical determinants of staphylococcal virulence FEMS Microbiol. Rev. 2014 38 698 719 10.1111/1574-6976.12057 24372362 PMC4072763 · DOI
  64. [73]Fey P.D. Olson M.E. Current concepts in biofilm formation of Staphylococcus epidermidis Future Microbiol. 2010 5 917 933 10.2217/fmb.10.56 20521936 PMC2903046 · DOI
  65. [74]O’Gara J.P. Humphreys H. Staphylococcus epidermidis biofilms: Importance and implications J. Med. Microbiol. 2001 50 582 587 10.1099/0022-1317-50-7-582 11444767 · DOI
  66. [75]Mekni M.A. Bouchami O. Achour W. Ben Hassen A. Strong biofilm production but not adhesion virulence factors can discriminate between invasive and commensal Staphylococcus epidermidis strains APMIS 2012 120 605 611 10.1111/j.1600-0463.2012.02877.x 22779682 · DOI
  67. [76]Heilmann C. Adhesion Mechanisms of Staphylococci Adv. Exp. Med. Biol. 2011 715 105 123 21557060
  68. [77]Vuong C. Gerke C. Somerville G.A. Fischer E.R. Otto M. Quorum-Sensing Control of Biofilm Factors in Staphylococcus epidermidis J. Infect. Dis. 2003 188 706 718 10.1086/377239 12934187 · DOI
  69. [78]Mack D. Davies A.P. Harris L.G. Rohde H. Horstkotte M.A. Knobloch J.K.-M. Microbial interactions in Staphylococcus epidermidis biofilms Anal. Bioanal. Chem. 2007 387 399 408 10.1007/s00216-006-0745-2 16955256 · DOI
  70. [79]Le K.Y. Otto M. Quorum-sensing regulation in staphylococci—An overview Front. Microbiol. 2015 6 1174 10.3389/fmicb.2015.01174 26579084 PMC4621875 · DOI
  71. [80]Chen X. Schauder S. Potier N. Van Dorsselaer A. Pelczer I. Bassler B.L. Hughson F.M. Structural identification of a bacterial quorum-sensing signal containing boron Nature 2002 415 545 549 10.1038/415545a 11823863 · DOI
  72. [81]Downing D.T. Stewart M.E. Wertz P.W. Strauss J.S. Essential fatty acids and acne J. Am. Acad. Dermatol. 1986 14 221 225 10.1016/S0190-9622(86)70025-X 2936775 · DOI
  73. [83]Ottaviani M. Alestas T. Flori E. Mastrofrancesco A. Zouboulis C.C. Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: A possible role in acne vulgaris J. Investig. Dermatol. 2006 126 2430 2437 10.1038/sj.jid.5700434 16778793 · DOI
  74. [84]Jahns A.C. Lundskog B. Ganceviciene R. Palmer R.H. Golovleva I. Zouboulis C.C. McDowell A. Patrick S. Alexeyev O.A. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: A case-control study Br. J. Dermatol. 2012 167 50 58 10.1111/j.1365-2133.2012.10897.x 22356121 · DOI
  75. [85]Dréno B. What is new in the pathophysiology of acne, an overview J. Eur. Acad. Dermatol. Venereol. 2017 31 8 12 10.1111/jdv.14374 28805938 · DOI
  76. [86]Dagnelie M.-A. Corvec S. Saint-Jean M. Bourdès V. Nguyen J.-M. Khammari A. Dréno B. La sévérité de l’acné est associée à une perte de la diversité des souches de Propionibacterium acnes en peau acnéique Ann. Dermatol. Venereol. 2017 144 S130 10.1016/j.annder.2017.09.168 · DOI
  77. [87]Dagnelie M.-A. Corvec S. Saint-Jean M. Nguyen J.M. Khammari A. Dréno B. Cutibacterium acnes phylotypes diversity loss: A trigger for skin inflammatory process J. Eur. Acad. Dermatol. Venereol. 2019 33 2340 2348 10.1111/jdv.15795 31299116 · DOI
  78. [88]Paugam C. Corvec S. Saint-Jean M. Le Moigne M. Khammari A. Boisrobert A. Nguyen J.M. Gaultier A. Dréno B. Propionibacterium acnes phylotypes and acne severity: An observational prospective study J. Eur. Acad. Dermatol. Venereol. 2017 31 e398 e399 10.1111/jdv.14206 28295699 · DOI
  79. [89]Higaki S. Kitagawa T. Kagoura M. Morohashi M. Yamagishi T. Correlation between Propionibacterium acnes Biotypes, Lipase Activity and Rash Degree in Acne Patients J. Dermatol. 2000 27 519 522 10.1111/j.1346-8138.2000.tb02219.x 10989576 · DOI
  80. [90]Oyewole A.O. Birch-Machin M.A. Sebum, inflammasomes and the skin: Current concepts and future perspective Exp. Dermatol. 2015 24 651 654 10.1111/exd.12774 26014614 · DOI
  81. [91]Shu M. Kuo S. Wang Y. Jiang Y. Liu Y.-T. Gallo R.L. Huang C.-M. Porphyrin Metabolisms in Human Skin Commensal Propionibacterium acnes Bacteria: Potential Application to Monitor Human Radiation Risk Curr. Med. Chem. 2013 20 562 568 23231351 PMC3878905
  82. [92]Johnson T. Kang D. Barnard E. Li H. Strain-Level Differences in Porphyrin Production and Regulation in Propionibacterium acnes Elucidate Disease Associations mSphere 2016 1 e00023-15 10.1128/mSphere.00023-15 27303708 PMC4863617 · DOI
  83. [93]Nazipi S. Stødkilde K. Scavenius C. Brüggemann H. The Skin Bacterium Propionibacterium acnes Employs Two Variants of Hyaluronate Lyase with Distinct Properties Microorganisms 2017 5 57 10.3390/microorganisms5030057 PMC5620648 28895889 · DOI
  84. [94]Dréno B. Pécastaings S. Corvec S. Veraldi S. Khammari A. Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: A brief look at the latest updates J. Eur. Acad. Dermatol. Venereol. 2018 32 5 14 10.1111/jdv.15043 29894579 · DOI
  85. [95]Liu P.F. Nakatsuji T. Zhu W. Gallo R.L. Huang C.M. Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris Vaccine 2011 29 3230 3238 10.1016/j.vaccine.2011.02.036 21354482 PMC3388602 · DOI
  86. [96]Nakatsuji T. Tang D.C. Zhang L. Gallo R.L. Huang C.M. Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: Potential targets for inflammatory acne treatment PLoS ONE 2011 6 e14797 10.1371/journal.pone.0014797 21533261 PMC3075254 · DOI
  87. [97]Beylot C. Auffret N. Poli F. Claudel J.P. Leccia M.T. Del Giudice P. Dréno B. Propionibacterium acnes: An update on its role in the pathogenesis of acne J. Eur. Acad. Dermatol. Venereol. 2014 28 271 278 10.1111/jdv.12224 23905540 · DOI
  88. [98]Borrel V. Gannesen A.V. Barreau M. Gaviard C. Duclairoir-Poc C. Hardouin J. Konto-Ghiorghi Y. Lefeuvre L. Feuilloley M.G.J. Adaptation of acneic and non acneic strains of Cutibacterium acnes to sebum-like environment Microbiologyopen 2019 8 e00841 10.1002/mbo3.841 30950214 PMC6741132 · DOI
  89. [99]Coenye T. Peeters E. Nelis H.J. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors Res. Microbiol. 2007 158 386 392 10.1016/j.resmic.2007.02.001 17399956 · DOI
  90. [100]Gannesen A.V. Lesouhaitier O. Racine P.-J. Barreau M. Netrusov A.I. Plakunov V.K. Feuilloley M.G.J. Regulation of Monospecies and Mixed Biofilms Formation of Skin Staphylococcus aureus and Cutibacterium acnes by Human Natriuretic Peptides Front. Microbiol. 2018 9 2912 10.3389/fmicb.2018.02912 30619105 PMC6296281 · DOI
  91. [101]Achermann Y. Goldstein E.J.C. Coenye T. Shirtliffa M.E. Propionibacterium acnes: From Commensal to Opportunistic Biofilm-Associated Implant Pathogen Clin. Microbiol. Rev. 2014 27 419 440 10.1128/CMR.00092-13 24982315 PMC4135900 · DOI
  92. [102]Holmberg A. Lood R. Mörgelin M. Söderquist B. Holst E. Collin M. Christensson B. Rasmussen M. Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates Clin. Microbiol. Infect. 2009 15 787 795 10.1111/j.1469-0691.2009.02747.x 19392888 · DOI
  93. [103]Ionescu M.-A.A. Feuilloley M.G.J. Enault J. Saguet T. Robert G. Lefeuvre L. La modulation du microbiofilm et du P. acnes ribotypes 4 et 5 dans l’acné polymorphe: Étude microbiologique in vitro et essai clinique dans une série de 70 cas Ann. Dermatol. Venereol. 2015 142 S434 S435 10.1016/j.annder.2015.10.030 · DOI
  94. [104]Kuehnast T. Cakar F. Weinhäupl T. Pilz A. Selak S. Schmidt M.A. Rüter C. Schild S. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates Int. J. Med. Microbiol. 2018 308 1027 1035 10.1016/j.ijmm.2018.09.005 30268774 · DOI
  95. [105]Burkhart C.G. Burkhart C.N. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug J. Am. Acad. Dermatol. 2007 57 722 724 10.1016/j.jaad.2007.05.013 17870436 · DOI
  96. [106]Lee Y.B. Byun E.J. Kim H.S. Potential Role of the Microbiome in Acne: A Comprehensive Review J. Clin. Med. 2019 8 987 10.3390/jcm8070987 PMC6678709 31284694 · DOI
  97. [107]Choi J.Y. Piao M.S. Lee J.B. Oh J.S. Kim I.G. Lee S.C. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-α in human dermal fibroblasts J. Investig. Dermatol. 2008 128 846 854 10.1038/sj.jid.5701188 18049448 · DOI
  98. [108]Jugeau S. Tenaud I. Knol A.C. Jarrousse V. Quereux G. Khammari A. Dréno B. Induction of toll-like receptors by Propionibacterium acnes Br. J. Dermatol. 2005 153 1105 1113 10.1111/j.1365-2133.2005.06933.x 16307644 · DOI
  99. [109]Nagy I. Pivarcsi A. Kis K. Koreck A. Bodai L. McDowell A. Seltmann H. Patrick S. Zouboulis C.C. Kemény L. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes Microbes Infect. 2006 8 2195 2205 10.1016/j.micinf.2006.04.001 16797202 · DOI · Paper page
  100. [110]Jarrousse V. Castex-Rizzi N. Khammari A. Charveron M. Dréno B. Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes Arch. Dermatol. Res. 2007 299 441 447 10.1007/s00403-007-0774-5 17684752 · DOI
  101. [111]Akaza N. Akamatsu H. Kishi M. Mizutani H. Ishii I. Nakata S. Matsunaga K. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro J. Dermatol. 2009 36 213 223 10.1111/j.1346-8138.2009.00626.x 19348660 · DOI
  102. [112]Feuilloley M.G.J. Antidromic neurogenic activity and cutaneous bacterial flora Semin. Immunopathol. 2018 50 281 289 10.1007/s00281-018-0671-3 29549404 · DOI
  103. [113]Roosterman D. Goerge T. Schneider S.W. Bunnett N.W. Steinhoff M. Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ Physiol. Rev. 2006 86 1309 1379 10.1152/physrev.00026.2005 17015491 · DOI
  104. [114]Racine P. Janvier X. Clabaut M. Catovic C. Souak D. Boukerb A.M. Groboillot A. Konto-Ghiorghi Y. Duclairoir-Poc C. Lesouhaitier O. Dialog between skin and its microbiota: Emergence of “Cutaneous Bacterial Endocrinology” Exp. Dermatol. 2020 29 exd.14158 10.1111/exd.14158 32682345 · DOI
  105. [115]Choi J.E. Di Nardo A. Skin Neurogenic inflammation Semin. Immunopathol. 2018 40 249 259 10.1007/s00281-018-0675-z 29713744 PMC6047518 · DOI
  106. [116]Lesouhaitier O. Clamens T. Rosay T. Desriac F. Louis M. Rodrigues S. Gannesen A.V. Plakunov V.K. Bouffartigues E. Tahrioui A. Host Peptidic Hormones Affecting Bacterial Biofilm Formation and Virulence J. Innate Immun. 2019 11 227 241 10.1159/000493926 30396172 PMC6738206 · DOI
  107. [117]Maksimovic S. Baba Y. Lumpkin E.A. Neurotransmitters and synaptic components in the Merkel cell-neurite complex, a gentle-touch receptor Ann. N. Y. Acad. Sci. 2013 1279 13 21 10.1111/nyas.12057 23530998 PMC3638015 · DOI
  108. [118]Kähler C.M. Sitte B.A. Reinisch N. Wiedermann C.J. Stimulation of the chemotactic migration of human fibroblasts by substance P Eur. J. Pharmacol. 1993 249 281 286 10.1016/0014-2999(93)90523-K 7507058 · DOI
  109. [119]Mijouin L. Hillion M. Ramdani Y. Jaouen T. Duclairoir-Poc C. Follet-Gueye M.-L. Lati E. Yvergnaux F. Driouich A. Lefeuvre L. Effects of a Skin Neuropeptide (Substance P) on Cutaneous Microflora PLoS ONE 2013 8 e78773 10.1371/journal.pone.0078773 24250813 PMC3826737 · DOI
  110. [120]N’Diaye A. Mijouin L. Hillion M. Diaz S. Konto-Ghiorghi Y. Percoco G. Chevalier S. Lefeuvre L. Harmer N.J. Lesouhaitier O. Effect of Substance P in Staphylococcus aureus and Staphylococcus epidermidis virulence: Implication for skin homeostasis Front. Microbiol. 2016 7 506 10.3389/fmicb.2016.00506 27148195 PMC4832252 · DOI
  111. [121]N’Diaye A. Borrel V. Racine P.J. Clamens T. Depayras S. Maillot O. Schaack B. Chevalier S. Lesouhaitier O. Feuilloley M.G.J. Mechanism of action of the moonlighting protein EfTu as a Substance P sensor in Bacillus cereus Sci. Rep. 2019 9 1304 10.1038/s41598-018-37506-6 30718605 PMC6361937 · DOI
  112. [122]N’Diaye A. Leclerc C. Kentache T. Hardouin J. Poc C.D. Konto-Ghiorghi Y. Chevalier S. Lesouhaitier O. Feuilloley M.G.J. Skin-bacteria communication: Involvement of the neurohormone Calcitonin Gene Related Peptide (CGRP) in the regulation of Staphylococcus epidermidis virulence Sci. Rep. 2016 6 35379 10.1038/srep35379 27739485 PMC5064375 · DOI
  113. [123]N’Diaye A. Gannesen A.V. Borrel V. Maillot O. Enault J. Racine P.J. Plakunov V. Chevalier S. Lesouhaitier O. Feuilloley M.G.J. Substance P and calcitonin gene-related peptide: Key regulators of cutaneous microbiota homeostasis Front. Endocrinol. 2017 8 15 10.3389/fendo.2017.00015 28194136 PMC5277020 · DOI
  114. [124]Borrel V. Thomas P. Catovic C. Racine P.-J. Konto-Ghiorghi Y. Lefeuvre L. Duclairoir-Poc C. Zouboulis C.C. Feuilloley M.G.J. Acne and Stress: Impact of Catecholamines on Cutibacterium acnes Front. Med. 2019 6 155 10.3389/fmed.2019.00155 PMC6635461 31355200 · DOI
  115. [125]Potter L.R. Yoder A.R. Flora D.R. Antos L.K. Dickey D.M. Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications Handbook of Experimental Pharmacology Schmidt H.H.H.W. Hofmann F. Stasch J.-P. Springer Berlin/Heidelberg, Germany 2009 Volume 191 341 366 9783540689607 PMC4855512 19089336
  116. [126]Gannesen A.V. Lesouhaitier O. Netrusov A.I. Plakunov V.K. Feuilloley M.G.J. Regulation of Formation of Monospecies and Binary Biofilms by Human Skin Microbiota Components, Staphylococcus epidermidis and Staphylococcus aureus, by Human Natriuretic Peptides Microbiology 2018 87 597 609 10.1134/S0026261718050090 PMC6296281 30619105 · DOI
  117. [127]Rouaud-Tinguely P. Jugé R. Mainzer C. Boudier D. Roth M. Coppin H. Closs B. Analysis of cutaneous microbiota between two age-group of Caucasian women J. Investig. Dermatol. 2018 138 S171 10.1016/j.jid.2018.03.1019 · DOI
  118. [128]Shibagaki N. Suda W. Clavaud C. Bastien P. Takayasu L. Iioka E. Kurokawa R. Yamashita N. Hattori Y. Shindo C. Aging-related changes in the diversity of women’s skin microbiomes associated with oral bacteria Sci. Rep. 2017 7 10567 10.1038/s41598-017-10834-9 28874721 PMC5585242 · DOI
  119. [130]Wang Z. Choi J.E. Wu C.C. Di Nardo A. Skin commensal bacteria Staphylococcus epidermidis promote survival of melanocytes bearing UVB-induced DNA damage, while bacteria Propionibacterium acnes inhibit survival of melanocytes by increasing apoptosis Photodermatol. Photoimmunol. Photomed. 2018 34 405 414 10.1111/phpp.12411 29974533 · DOI
  120. [131]Christensen G.J.M. Scholz C.F.P. Enghild J. Rohde H. Kilian M. Thürmer A. Brzuszkiewicz E. Lomholt H.B. Brüggemann H. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis BMC Genom. 2016 17 152 10.1186/s12864-016-2489-5 PMC4770681 26924200 · DOI
  121. [132]Jo J.H. Kennedy E.A. Kong H.H. Research Techniques Made Simple: Bacterial 16S Ribosomal RNA Gene Sequencing in Cutaneous Research J. Investig. Dermatol. 2016 136 e23 e27 10.1016/j.jid.2016.01.005 26902128 PMC5482524 · DOI
  122. [133]Kong H.H. Andersson B. Clavel T. Common J.E. Jackson S.A. Olson N.D. Segre J.A. Traidl-Hoffmann C. Performing Skin Microbiome Research: A Method to the Madness J. Investig. Dermatol. 2017 137 561 568 10.1016/j.jid.2016.10.033 28063650 PMC5468751 · DOI
  123. [134]Grice E.A. Kong H.H. Renaud G. Young A.C. Bouffard G.G. Blakesley R.W. Wolfsberg T.G. Turner M.L. Segre J.A. Segre J.A. A diversity profile of the human skin microbiota Genome Res. 2008 18 1043 1050 10.1101/gr.075549.107 18502944 PMC2493393 · DOI
  124. [135]Van Horn K.G. Audette C.D. Tucker K.A. Sebeck D. Comparison of 3 swab transport systems for direct release and recovery of aerobic and anaerobic bacteria Diagn. Microbiol. Infect. Dis. 2008 62 471 473 10.1016/j.diagmicrobio.2008.08.004 18814991 · DOI
  125. [136]Lange-Asschenfeldt B. Marenbach D. Lang C. Patzelt A. Ulrich M. Maltusch A. Terhorst D. Stockfleth E. Sterry W. Lademann J. Distribution of bacteria in the epidermal layers and hair follicles of the human skin Skin Pharmacol. Physiol. 2011 24 305 311 10.1159/000328728 21757977 · DOI
  126. [137]Ogai K. Nagase S. Mukai K. Iuchi T. Mori Y. Matsue M. Sugitani K. Sugama J. Okamoto S. A Comparison of Techniques for Collecting Skin Microbiome Samples: Swabbing Versus Tape-Stripping Front. Microbiol. 2018 9 2362 10.3389/fmicb.2018.02362 30333815 PMC6176111 · DOI
  127. [138]Prast-Nielsen S. Tobin A.-M. Adamzik K. Powles A. Hugerth L.W. Sweeney C. Kirby B. Engstrand L. Fry L. Investigation of the skin microbiome: Swabs vs. biopsies Br. J. Dermatol. 2019 181 572 579 30693476
  128. [139]Cangelosi G.A. Meschke J.S. Dead or alive: Molecular assessment of microbial viability Appl. Environ. Microbiol. 2014 80 5884 5891 10.1128/AEM.01763-14 25038100 PMC4178667 · DOI
  129. [140]Bashiardes S. Zilberman-Schapira G. Elinav E. Use of metatranscriptomics in microbiome research Bioinform. Biol. Insights 2016 10 19 25 10.4137/BBI.S34610 27127406 PMC4839964 · DOI
  130. [141]Meisel J.S. Hannigan G.D. Tyldsley A.S. SanMiguel A.J. Hodkinson B.P. Zheng Q. Grice E.A. Skin microbiome surveys are strongly influenced by experimental design J. Investig. Dermatol. 2016 136 947 956 10.1016/j.jid.2016.01.016 26829039 PMC4842136 · DOI
  131. [142]Feuilloley M.G.J. Skin microbiota: Variability and new perspectives Proceedings of the The Microbiome of the Skin-New Avenues of Research, in Cosmetics Amsterdam, The Netherlands 17 April 2018
  132. [143]Krutmann J. Pre- and probiotics for human skin J. Dermatol. Sci. 2009 54 1 5 10.1016/j.jdermsci.2009.01.002 19203862 · DOI
  133. [144]Azeredo J. Azevedo N.F. Briandet R. Cerca N. Coenye T. Costa A.R. Desvaux M. Di Bonaventura G. Hébraud M. Jaglic Z. Critical review on biofilm methods Crit. Rev. Microbiol. 2017 43 313 351 10.1080/1040841X.2016.1208146 27868469 · DOI
  134. [145]Jahns A.C. Oprica C. Vassilaki I. Golovleva I. Palmer R.H. Alexeyev O.A. Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and fluorescence in situ hybridization Anaerobe 2013 23 48 54 10.1016/j.anaerobe.2013.07.002 23896347 · DOI
  135. [146]Peeters E. Nelis H.J. Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates J. Microbiol. Methods 2008 72 157 165 10.1016/j.mimet.2007.11.010 18155789 · DOI
  136. [147]Coenye T. Nelis H.J. In vitro and in vivo model systems to study microbial biofilm formation J. Microbiol. Methods 2010 83 89 105 10.1016/j.mimet.2010.08.018 20816706 · DOI
  137. [148]Gannesen A.V. Zdorovenko E.L. Botchkova E.A. Hardouin J. Massier S. Kopitsyn D.S. Gorbachevskii M.V. Kadykova A.A. Shashkov A.S. Zhurina M.V. Composition of the biofilm matrix of Cutibacterium acnes acneic strain RT5 Front. Microbiol. 2019 10 1284 10.3389/fmicb.2019.01284 31293526 PMC6598116 · DOI
  138. [150]Vogelgesang B. (BASF Beauty Care Solutions France) Recent advances and new strategies to substantiate microbiota-related cosmetic claims Proceedings of the The Microbiome of the Skin-New Avenues of Research, in Cosmetics Amsterdam, The Netherlands 17 April 2018
  139. [151]Krieken D. Ederveen T. Hijum S. Jansen P. Melchers W. Scheepers P. Schalkwijk J. Zeeuwen P. An in vitro model for bacterial growth on human stratum corneum Acta Derm. Venereol. 2016 96 873 879 10.2340/00015555-2401 26976779 · DOI · Paper page
  140. [152]Niehues H. Bouwstra J.A. El Ghalbzouri A. Brandner J.M. Zeeuwen P.L.J.M. van den Bogaard E.H. 3D skin models for 3R research: The potential of 3D reconstructed skin models to study skin barrier function Exp. Dermatol. 2018 27 501 511 10.1111/exd.13531 29518287 · DOI · Paper page
  141. [154]Holland D.B. Bojar R.A. Jeremy A.H.T. Ingham E. Holland K.T. Microbial colonization of an in vitro model of a tissue engineered human skin equivalent—A novel approach FEMS Microbiol. Lett. 2008 279 110 115 10.1111/j.1574-6968.2007.01021.x 18081841 · DOI
  142. [155]Duckney P. Wong H.K. Serrano J. Yaradou D. Oddos T. Stamatas G.N. The role of the skin barrier in modulating the effects of common skin microbial species on the inflammation, differentiation and proliferation status of epidermal keratinocytes BMC Res. Notes 2013 6 474 10.1186/1756-0500-6-474 24245826 PMC4225502 · DOI
  143. [157]Landemaine L. Cenizo V. Lemaire G. Portes P. Colonization of a 3D skin model with a complete microbiota is more beneficial to the skin barrier than with Staphylococcus epidermidis alone J. Investig. Dermatol. 2018 138 S163 10.1016/j.jid.2018.03.973 · DOI · Paper page
  144. [158]Rademacher F. Simanski M. Gläser R. Harder J. Skin microbiota and human 3D skin models Exp. Dermatol. 2018 27 489 494 10.1111/exd.13517 29464787 · DOI · Paper page
  145. [159]Kuhbacher A. Henkel H. Stevens P. Grumaz C. Finkelmeier D. Burger-Kentischer A. Sohn K. Rupp S. Dermal Fibroblasts Play a Central Role in Skin Model Protection against Candida albicans Invasion J. Infect. Dis. 2017 215 1742 1752 10.1093/infdis/jix153 28368492 · DOI
  146. [160]Holland K.T. Bojar R.A. Cosmetics: What is their influence on the skin microflora? Am. J. Clin. Dermatol. 2002 3 445 449 10.2165/00128071-200203070-00001 12180892 · DOI
  147. [161]Wang Q. Cui S. Zhou L. He K. Song L. Liang H. He C. Effect of cosmetic chemical preservatives on resident flora isolated from healthy facial skin J. Cosmet. Dermatol. 2019 18 652 658 10.1111/jocd.12822 30548758 · DOI
  148. [162]Staudinger T. Pipal A. Redl B. Molecular analysis of the prevalent microbiota of human male and female forehead skin compared to forearm skin and the influence of make-up J. Appl. Microbiol. 2011 110 1381 1389 10.1111/j.1365-2672.2011.04991.x 21362117 · DOI
  149. [163]Lee H.J. Jeong S.E. Lee S. Kim S. Han H. Jeon C.O. Effects of cosmetics on the skin microbiome of facial cheeks with different hydration levels Microbiologyopen 2017 7 e00557 10.1002/mbo3.557 29193830 PMC5911989 · DOI
  150. [164]Dobler D. Schmidts T. Wildenhain S. Seewald I. Merzhäuser M. Runkel F. Impact of Selected Cosmetic Ingredients on Common Microorganisms of Healthy Human Skin Cosmetics 2019 6 45 10.3390/cosmetics6030045 · DOI
  151. [165]Callewaert C. Hutapea P. Van de Wiele T. Boon N. Deodorants and antiperspirants affect the axillary bacterial community Arch. Dermatol. Res. 2014 306 701 710 10.1007/s00403-014-1487-1 25077920 · DOI
  152. [166]Wallen-Russell C. The Role of Every-Day Cosmetics in Altering the Skin Microbiome: A Study Using Biodiversity Cosmetics 2018 6 2 10.3390/cosmetics6010002 · DOI
  153. [167]Lopes E.G. Moreira D.A. Gullón P. Gullón B. Cardelle-Cobas A. Tavaria F.K. Topical application of probiotics in skin: Adhesion, antimicrobial and antibiofilm in vitro assays J. Appl. Microbiol. 2017 122 450 461 10.1111/jam.13349 27862685 · DOI
  154. [168]Shokryazdan P. Sieo C.C. Kalavathy R. Liang J.B. Alitheen N.B. Faseleh Jahromi M. Ho Y.W. Probiotic potential of Lactobacillus strains with antimicrobial activity against some human pathogenic strains BioMed Res. Int. Int. 2014 2014 927268 10.1155/2014/927268 PMC4106073 25105147 · DOI
  155. [169]Khmaladze I. Butler É. Fabre S. Gillbro J.M. Lactobacillus reuteri DSM 17938—A comparative study on the effect of probiotics and lysates on human skin Exp. Dermatol. 2019 28 822 828 10.1111/exd.13950 31021014 · DOI
  156. [170]Hillion M. Interactions peau/microbiote cutané: Étude du microbiote cutané cultivable et influence de produits cosmétiques sur la virulence bactérienne. Apports de la technique de spectrométrie de masse MALDI-TOF Ph.D. Thesis Thèse de l’Université de Rouen Évreux, France 2013
  157. [171]Baldwin H.E. Bhatia N.D. Friedman A. Eng R.M. Seite S. The role of cutaneous microbiota harmony in maintaining a functional skin barrier J. Drugs Dermatol. 2017 16 12 18 10.25251/skin.1.supp.138 28095528 · DOI
  158. [172]Seite S. Misery L. Skin sensitivity and skin microbiota: Is there a link? Exp. Dermatol. 2018 27 1061 1064 10.1111/exd.13686 29781556 · DOI
  159. [173]Cinque B. Palumbo P. La Torre C. Melchiorre E. Corridoni D. Miconi G. Di Marzio L. Cifone M.G. Giuliani M. Probiotics in aging skin Textbook of Aging Skin Farage M.A. Miller K.W. Howard I M. Springer Berlin/Heidelberg, Germany 2010 811 820 9783540896555
  160. [175]Paetzold B. Willis J.R. Pereira De Lima J. Knödlseder N. Brüggemann H. Quist S.R. Gabaldón T. Güell M. Skin microbiome modulation induced by probiotic solutions Microbiome 2019 7 95 10.1186/s40168-019-0709-3 31234928 PMC6591853 · DOI
  161. [180]De Jesus Raposo M.F. De Morais A.M.M.B. De Morais R.M.S.C. Emergent sources of prebiotics: Seaweeds and microalgae Mar. Drugs 2016 14 27 10.3390/md14020027 PMC4771980 26828501 · DOI · Paper page
  162. [183]Misery L. Myon E. Martin N. Verrière F. Nocera T. Taieb C. Sensitive skin in France: An epidemiological approach Ann. Dermatol. Venereol. 2005 132 425 429 10.1016/S0151-9638(05)79303-0 15988353 · DOI
  163. [184]Berardesca E. Farage M. Maibach H. Sensitive skin: An overview Int. J. Cosmet. Sci. 2013 35 2 8 10.1111/j.1468-2494.2012.00754.x 22928591 · DOI
  164. [185]Farage M.A. Katsarou A. Maibach H.I. Sensory, clinical and physiological factors in sensitive skin: A review Contact Dermat. 2006 55 1 14 10.1111/j.0105-1873.2006.00886.x 16842547 · DOI
  165. [186]Hillion M. Mijouin L. Jaouen T. Barreau M. Meunier P. Lefeuvre L. Lati E. Chevalier S. Feuilloley M.G.J. Comparative study of normal and sensitive skin aerobic bacterial populations Microbiologyopen 2013 2 953 961 10.1002/mbo3.138 24151137 PMC3892341 · DOI
  166. [188]Nodake Y. Matsumoto S. Miura R. Honda H. Ishibashi G. Matsumoto S. Dekio I. Sakakibara R. Pilot study on novel skin care method by augmentation with Staphylococcus epidermidis, an autologous skin microbe—A blinded randomized clinical trial J. Dermatol. Sci. 2015 79 119 126 10.1016/j.jdermsci.2015.05.001 26012780 · DOI
  167. [189]Lew L.-C. Liong M.-T. Bioactives from probiotics for dermal health: Functions and benefits J. Appl. Microbiol. 2013 114 1241 1253 10.1111/jam.12137 23311666 · DOI · Paper page
  168. [191]Knobloch J.K.M. Bartscht K. Sabottke A. Rohde H. Feucht H.H. Mack D. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: Differential activation mechanisms due to ethanol and salt stress J. Bacteriol. 2001 183 2624 2633 10.1128/JB.183.8.2624-2633.2001 11274123 PMC95180 · DOI
  169. [192]Gannesen A.V. Borrel V. Lefeuvre L. Netrusov A.I. Plakunov V.K. Feuilloley M.G.J. Effect of two cosmetic compounds on the growth, biofilm formation activity, and surface properties of acneic strains of Cutibacterium acnes and Staphylococcus aureus Microbiologyopen 2018 8 e00659 10.1002/mbo3.659 29911330 PMC6436439 · DOI
  170. [193]Enault J. Saguet T. Yvergnaux F. Feuilloley M.G.J. PS291®, a rhamnose-rich polysaccharide obtained by fermentation, is reducing Propionibacterium acnes adhesion and biofilm formation activity Proceedings of the International Federation of Societies of Cosmetic Chemists Paris, France 30 October 2014 2801 2810
  171. [194]Filaire E. Vialleix C. Cadoret J.-P. Guénard S. Muller C. Dreux-Zigha A. Berthon J.-Y. Characterization of Reactive and Sensitive Skin Microbiota: Effect of Halymenia durvillei (HD) Extract Treatment Cosmetics 2019 6 69 10.3390/cosmetics6040069 · DOI
  172. [195]Feuillolay C. Pecastaings S. Gac C.L. Fiorini-Puybaret C. Luc J. Joulia P. Roques C. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris Phytomedicine 2016 23 307 315 10.1016/j.phymed.2015.11.016 26969384 · DOI
  173. [196]Trompezinski S. Weber S. Cadars B. Larue F. Ardiet N. Chavagnac-Bonneville M. Sayag M. Jourdan E. Assessment of a new biological complex efficacy on dysseborrhea, inflammation, and Propionibacterium acnes proliferation Clin. Cosmet. Investig. Dermatol. 2016 9 233 239 PMC5012630 27621660
  174. [197]Saising J. Voravuthikunchai S.P. Anti Propionibacterium acnes activity of rhodomyrtone, an effective compound from Rhodomyrtus tomentosa (Aiton) Hassk. leaves Anaerobe 2012 18 400 404 10.1016/j.anaerobe.2012.05.003 22626672 · DOI
  175. [200]Petigny L. Périno-Issartier S. Wajsman J. Chemat F. Batch and Continuous Ultrasound Assisted Extraction of Boldo Leaves (Peumus boldus Mol.) Int. J. Mol. Sci 2013 14 5750 5764 10.3390/ijms14035750 23481637 PMC3634473 · DOI
  176. [203]Wunnoo S. Saising J. Voravuthikunchai S.P. Rhodomyrtone inhibits lipase production, biofilm formation, and disorganizes established biofilm in Propionibacterium acnes Anaerobe 2017 43 61 68 10.1016/j.anaerobe.2016.12.002 27923605 · DOI
  177. [204]Borrel V. Influence du microenvironnement sur la virulence et la formation de biofilm de Cutibacterium acnes Ph.D. Thesis Thèse de l’Université de Rouen Évreux, France 2019
  178. [205]Zeichner J.A. The use of lipohydroxy acid in skin care and acne treatment J. Clin. Aesthet. Dermatol. 2016 9 40 43 10.25251/skin.1.supp.55 PMC5300717 28210389 · DOI
  179. [206]Choi J.S. Bae H.J. Kim S.J. Choi I.S. In vitro antibacterial and anti-inflammatory properties of seaweed extracts against acne inducing bacteria, Propionibacterium acnes J. Environ. Biol. 2011 32 313 318 22167943
  180. [207]Kamei Y. Sueyoshi M. Hayashi K.I. Terada R. Nozaki H. The novel anti-Propionibacterium acnes compound, Sargafuran, found in the marine brown alga Sargassum macrocarpum J. Antibiot. 2009 62 259 263 10.1038/ja.2009.25 19329987 · DOI
  181. [208]Katsuta R. Aoki K. Yajima A. Nukada T. Synthesis of the core framework of the proposed structure of sargafuran Tetrahedron Lett. 2013 54 347 350 10.1016/j.tetlet.2012.11.052 · DOI
  182. [209]Amiguet V.T. Jewell L.E. Mao H. Sharma M. Hudson J.B. Durst T. Allard M. Rochefort G. Arnason J.T. Antibacterial properties of a glycolipid-rich extract and active principle from Nunavik collections of the macroalgae Fucus evanescens C. Agardh (Fucaceae) Can. J. Microbiol. 2011 57 745 749 10.1139/w11-065 21859295 · DOI
  183. [210]Lee J.-H. Eom S.-H. Lee E.-H. Jung Y.-J. Kim H.-J. Jo M.-R. Son K.-T. Lee H.-J. Kim J.H. Lee M.-S. In vitro antibacterial and synergistic effect of phlorotannins isolated from edible brown seaweed Eisenia bicyclis against acne-related bacteria ALGAE 2014 29 47 55 10.4490/algae.2014.29.1.047 · DOI
  184. [212]Al-Ghazzewi F.H. Khanna S. Tester R.F. Piggott J. The potential use of hydrolysed konjac glucomannan as a prebiotic J. Sci. Food Agric. 2007 87 1758 1766 10.1002/jsfa.2919 · DOI
  185. [213]Al-Ghazzewi F.H. Tester R.F. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro Int. J. Cosmet. Sci. 2010 32 139 142 10.1111/j.1468-2494.2009.00555.x 19818083 · DOI
  186. [214]Yang A.-J. Marito S. Yang J.-J. Keshari S. Chew C.-H. Chen C.-C. Huang C.-M. A Microtube Array Membrane (MTAM) Encapsulated Live Fermenting Staphylococcus epidermidis as a Skin Probiotic Patch against Cutibacterium acnes Int. J. Mol. Sci. 2018 20 14 10.3390/ijms20010014 PMC6337527 30577530 · DOI
  187. [215]Castillo D.E. Nanda S. Keri J.E. Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives Dermatol. Ther. 2019 9 19 31 10.1007/s13555-018-0275-9 PMC6380980 30539425 · DOI
  188. [216]Marinelli L.J. Fitz-Gibbon S. Hayes C. Bowman C. Inkeles M. Loncaric A. Russell D.A. Jacobs-Sera D. Cokus S. Pellegrini M. Propionibacterium acnes Bacteriophages Display Limited Genetic Diversity and Broad Killing Activity against Bacterial Skin Isolates mBio 2012 3 e00279-12 10.1128/mBio.00279-12 23015740 PMC3448167 · DOI
  189. [217]Jończyk-Matysiak E. Weber-Dąbrowska B. Żaczek M. Międzybrodzki R. Letkiewicz S. Łusiak-Szelchowska M. Górski A. Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes Front. Microbiol. 2017 8 164 10.3389/fmicb.2017.00164 28228751 PMC5296327 · DOI
  190. [218]Liu J. Yan R. Zhong Q. Ngo S. Bangayan N.J. Nguyen L. Lui T. Liu M. Erfe M.C. Craft N. The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin ISME J. 2015 9 2078 2093 10.1038/ismej.2015.47 25848871 PMC4542041 · DOI
  191. [219]Gervason S. Metton I. Gemrot E. Ranouille E. Skorski G. Cabannes M. Berthon J.-Y. Filaire E. Rhodomyrtus tomentosa Fruit Extract and Skin Microbiota: A Focus on C. acnes Phylotypes in Acne Subjects Cosmetics 2020 7 53 10.3390/cosmetics7030053 · DOI
  192. [220]Cinque B. La Torre C. Melchiorre E. Marchesani G. Zoccali G. Palumbo P. Di Marzio L. Masci A. Mosca L. Mastromarino P. Use of Probiotics for Dermal Applications Probiotics Liong M.-T. Springer Berlin/Heidelberg, Germany 2011 221 241 978-3-642-20838-6
  193. [221]Bey M. Nachat-Kapes R. Ranouille E. Berthon J. Targeting skin microbiome: Innovative approach for the development of cosmetic active ingredients Proceedings of the COSM’ING 2016 Saint Malo, France 29 June 2016 13
  194. [223]Rouaud-Tinguely P. Laporte D. Bordes S. Roth M.-P. Coppin H. Closs B. Microbiota: A Topic at The Crossroads of Many Fields of Expertise Proceedings of the COSM’ING 2018 Saint Malo, France 4–6 July 2018 4
  195. [224]Al-Ghazzewi F.H. Tester R.F. Impact of prebiotics and probiotics on skin health Benef. Microbes 2014 5 99 107 10.3920/BM2013.0040 24583611 · DOI

Cited by

Sorted by citations

Authors
Fournière, M., Latire, T., Souak, D., Feuilloley, M. G. J., & Bedoux, G.
Affiliations
  • Université catholique de l'ouest (FR)
  • Université de Rouen Normandie (FR)
  • Université de Bretagne Occidentale (FR)
Corresponding author
Fournière, Mathilde
Venue
Microorganisms
Publisher
MDPI AG
Published
2020-11-07
Volume
8
Issue
11
Pages
1752
ISSN
2076-2607 (ISSN-L)
OpenAlex
W3096857144
Cited by
227
References
13
Citations by year
2026: 31 · 2025: 43 · 2024: 50 · 2023: 53 · 2022: 29 · 2021: 20 · 2020: 1
FWCI
4.31
Type
journal article
Language
en
Open access
Locations
  • Microorganisms (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Conseil départemental des Côtes d’Armor (CD22) [INR00089] and Guingamp Paimpol Agglomération (GPA) (INR00089)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Keywords
Staphylococcus epidermidis, Propionibacterium acnes, skin microbiome, commensal bacteria, skin dysbiosis, biofilm, acne, atopic dermatitis, bacterial metabolites, skin homeostasis, cosmetics, cosmetic active ingredients, skin microenvironment, opportunistic pathogens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review